Jinye Xu

439 total citations
11 papers, 339 citations indexed

About

Jinye Xu is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jinye Xu has authored 11 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jinye Xu's work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Jinye Xu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Jinye Xu collaborates with scholars based in China, Hong Kong and Germany. Jinye Xu's co-authors include Wenxia Xu, Hongchuan Jin, Lifeng Feng, Xian Wang, Qiqi Shi, Jianwei Zhou, Zhinong Jiang, Xiaoling Qian, Jiaqiu Li and Yu Weng and has published in prestigious journals such as Energy & Fuels, Cell Death and Disease and Theranostics.

In The Last Decade

Jinye Xu

10 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinye Xu China 9 232 144 61 24 21 11 339
Jiefu Wang China 11 277 1.2× 127 0.9× 141 2.3× 23 1.0× 30 1.4× 32 418
Yulan Song China 10 281 1.2× 216 1.5× 59 1.0× 10 0.4× 11 0.5× 20 389
Longshan Zhang China 10 141 0.6× 80 0.6× 83 1.4× 19 0.8× 16 0.8× 16 267
Yuefeng Wang China 10 230 1.0× 119 0.8× 54 0.9× 12 0.5× 14 0.7× 18 350
Bingluo Zhou China 9 207 0.9× 106 0.7× 70 1.1× 45 1.9× 16 0.8× 11 293
H-S Hsu Taiwan 6 228 1.0× 120 0.8× 125 2.0× 11 0.5× 43 2.0× 6 441
Jimmy M-M. Kwok United Kingdom 5 553 2.4× 70 0.5× 173 2.8× 11 0.5× 54 2.6× 5 630
Mengchuan Wang China 13 274 1.2× 175 1.2× 106 1.7× 62 2.6× 33 1.6× 22 472

Countries citing papers authored by Jinye Xu

Since Specialization
Citations

This map shows the geographic impact of Jinye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinye Xu more than expected).

Fields of papers citing papers by Jinye Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinye Xu. The network helps show where Jinye Xu may publish in the future.

Co-authorship network of co-authors of Jinye Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinye Xu. A scholar is included among the top collaborators of Jinye Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinye Xu. Jinye Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Xu, Feng-Qing, Renzhong Wang, Siyu Wu, Jinye Xu, & Deling Wu. (2023). A Novel Phenanthrene and An Undescribed Alkaloid from the Roots of Stephania tetrandra. Records of Natural Products. 622–627.
2.
Yu, Lei, Bingluo Zhou, Ling Li, et al.. (2023). HSF1 promotes CD69+ Treg differentiation to inhibit colitis progression. Theranostics. 13(6). 1892–1905. 12 indexed citations
4.
Xu, Jinye, Qiqi Shi, Wenxia Xu, et al.. (2019). Metabolic enzyme PDK3 forms a positive feedback loop with transcription factor HSF1 to drive chemoresistance. Theranostics. 9(10). 2999–3013. 43 indexed citations
5.
Zhou, Qiyin, Wenxia Xu, Qiqi Shi, et al.. (2019). SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer. Cell Death and Disease. 10(5). 363–363. 50 indexed citations
6.
Xu, Wenxia, Bingluo Zhou, Xiaoya Zhao, et al.. (2018). KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance. International Journal of Biological Sciences. 14(9). 1122–1132. 46 indexed citations
7.
Xu, Wenxia, Qiqi Shi, Xiaoling Qian, et al.. (2018). Rab5a suppresses autophagy to promote drug resistance in cancer cells.. PubMed. 10(4). 1229–1236. 15 indexed citations
8.
Qian, Xiaoling, Wenxia Xu, Jinye Xu, et al.. (2017). Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer. Oncotarget. 8(29). 47691–47708. 103 indexed citations
9.
Chen, Guang, Jinye Xu, Jie Chen, et al.. (2016). Loss of PIG3 increases HIF-1α level by promoting protein synthesis via mTOR pathway in renal cell carcinoma cells. Oncotarget. 7(19). 27176–27184. 5 indexed citations
10.
Xu, Jinye, et al.. (2015). PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway. Oncology Reports. 34(3). 1424–1430. 26 indexed citations
11.
Liu, Yanmei, et al.. (2015). Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma. World Journal of Surgical Oncology. 14(1). 30–30. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026